PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-54

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    Yes didn't look if was updated but not sure what was presented given it was same day as ASX release
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.